William Gradishar, MD, on Advances in Endocrine Therapeutic Options for Patients With ER-Positive, HER2-Negative Breast Cancer
William Gradishar, MD, discusses advances in endocrine therapeutic options for patients with estrogen receptor–positive, HER2-negative breast cancer, in follow-up to his presentation at the Lynn Sage Breast Cancer Symposium, October 2024. Dr. Gradishar is the Betsy Bramsen Professor of Breast Oncology; Professor, Medicine (Hematology and Oncology), at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago.
Presented at the Lynn Sage Breast Cancer Symposium, hosted by the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago. Filmed November 1, 2024.